N-Boc Linagliptin
CAS No. | : 668273-75-4 |
Mol F. | : C30H36N8O4 |
Mol W. | : 572.66 |
Cat No. | : SA49904 |
- Description
- Quick Enquiry / RFQ
Description
Product Name | N-Boc Linagliptin |
Synonyms | tert-Butyl(R)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
(R)-Tert-Butyl (1-(7-(but- 2-yn-1-yl)-3-methyl-1-((4- methylquinazolin-2- yl)methyl)-2,6-dioxo- 2,3,6,7-tetrahydro-1Hpurin- 8-yl)piperidin-3- yl)carbamate N-[(3R)-1-[7-(2-Butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-carbamic Acid 1,1-Dimethylethyl Ester |
Related API | Linagliptin |
Category | Impurities |
N-Boc Linagliptin product with CAS: 668273-75-4 is also known as tert-Butyl(R)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate. This product can be used as a working standard or secondary reference standard. Additional internal validation as per respective FDA regulations/guidelines may require. N-Boc Linagliptin is generally used for Quality Control (QC), Quality Assurance (QA) during commercial production of Linagliptin and its related formulations. Moreover,tert-Butyl(R)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate is also used in the process of Abbreviated New Drug Application (ANDA) filing to FDA and toxicity study of respective drug formulation.
If you need different pack size / quantity, please contact us or email us at [email protected]